Abstract:Abstract Objectives The study objectives were to illustrate our workflow for lung donation and transplantation during the Coronavirus Disease 2019 crisis and to report our preliminary experience with perioperative care. Methods We retrospectively analyzed data in the China Lung Transplantation Registration from January 23, 2020, to March 23, 2020 (2020 cohort), compared with the same period in 2019 (2019 cohort). Pre– and post–lung transplantation management strategies, including measures aiming to prevent severe acute respiratory syndrome coronavirus 2 infection, were applied to all recipients, including 5 post–Coronavirus Disease 2019 transplants during the Coronavirus Disease 2019 pandemic period in China. Results Twenty-eight lung transplant procedures were performed, including lung transplant for 5 patients with acute respiratory distress syndrome due to Coronavirus Disease 2019–related pulmonary fibrosis. Compared with the 2019 cohort, more patients with urgent conditions received transplantation in 2020, with a shorter pre–lung transplant admission time and early mobilization post–lung transplant. A large proportion (60%) of lung donations were transported on high-speed trains and commercial flights or highways and commercial flights. Grafts in the preservation containers were handed over to the receiving staff at the airport for 40% (10/25) of donations, which reduced the unnecessary quarantine of transporting staff entering the city. Listed candidates were urgently transferred to other qualified centers in 17.9% of cases (5/28), which reduced the risk of severe acute respiratory syndrome coronavirus 2 exposure in Coronavirus Disease 2019–designated hospitals. The 90-day survival of the transplant recipients in 2020 was 85.7%, including 3 of 5 recipients (60%) who had critically severe Coronavirus Disease 2019. Conclusions Lung transplant and donation amid Coronavirus Disease 2019 can be performed safely with coordinated efforts on medical resource sharing and medical staff protection based on stratification of the infection risk. Outcomes were not compromised during the Coronavirus Disease 2019 outbreak. Lung transplantion can be regarded as salvage therapy for critical patients with Coronavirus Disease 2019 with a confirmed positive turned negative virology status.

Management of COVID-19 in Patients after Liver Transplantation: Beijing Working Party for Liver Transplantation

LUNG TRANSPLANTATION DURING THE OUTBREAK OF CORONAVIRUS DISEASE 2019: EARLY EXPERIENCE FROM CHINA

Lung transplantation during the outbreak of Coronavirus Disease 2019 in China

SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We Stand?

Management of COVID-19 patients with chronic liver diseases and liver transplants

Ppa_a_337448 61..68

Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19

Clinical Characteristics and Outcomes of Liver Transplant Recipients Infected by Omicron During the Opening Up of the Dynamic Zero-Coronavirus Disease Policy in China: A Prospective, Observational Study.

Liver Diseases in COVID-19: Etiology, Treatment and Prognosis

Liver Injury in Patients with COVID-19: A Retrospective Study

Liver diseases in COVID-19: Etiology, treatment and prognosis.

Clinical application of COVID-19 vaccine in liver transplant recipients

COVID-19 and the liver: What do we know so far?

Immunology of Transplant Patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy.

Successful management of concurrent COVID-19 and Pneumocystis Jirovecii Pneumonia in kidney transplant recipients: a case series

An Overview of Liver Transplantation: Current Status, Recent Techniques, and Challenges-Perspectives From a Center in China.

Practical experiences of managing COVID-19 in lung transplantation

Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China

COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management

Clinical characteristics and prognosis of SARS-CoV-2 infection in lung transplant recipients

Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients